Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver characterized by immune mediated destruction of bile ducts and high titer autoantibodies to mitochondrial components. The mitochondrial autoantigens are members of the 2-oxo acid dehydrogenase enzyme complex (the major autoantigen being PDC-E2). We have mapped B. and T cell autoepitopes in PDC-E2 and demonstrated heterogeneous TCR usage in PDC-E2 specific T cells. Further, we have made the important observation that there are markedly increased amounts of a molecule with some, but not all, of the properties of PDC-E2 on biliary epithelial cells (BEC) of PBC but not control patients. This is the only known difference between the BEC of PBC patients and controls and provides a clue as to why immune damage is focused on biliary epithelium. We have thus developed a hypothesis, we propose to test, that explains the selective destruction of BEC and the mechanisms involved in the immunopathology of PBC. Firstly, we will identify the molecule uniquely expressed in BEC in PBC. We will define whether the antigen is a cross-reactive molecule that shares a single and/or multiple autoantigenic epitopes, a truncated or otherwise processed form of PDC-E2, or a tissue specific isoform. If this is a cross-reactive molecule we will clone and sequence the gene encoding it. Secondly, we will determine if the increased expression of antigens in the BEC of PBC is limited to a PDC-E2 like molecule or whether there is also increased expression of molecules with similarity or crossreactivity to the other commonly recognized autoantigens BCOADC-E2 and OGDC-E2. The answer to this question will differentiate between widespread molecular mimicry or global upregulation of endogenous sequences. Finally, we will determine the temporal changes in the specificity of the immune response in PBC. We will determine whether the PDC-E2 like molecule on BEC is found in asymptomatic and early stage PBC and follow its expression during disease progression. We will also determine if there is a temporal progression in the cellular response in PBC and, if so, whether the peptides that induce the T cell responses can be identified and the precise MHC antigens that present such peptides be defined. Similarly, we will address the issues of progression of specific TCR V/beta and peptide-binding motifs. The availability of cDNAs for the autoantigens, cDNA BEC libraries, murine mAbs, combinatorial Abs, and an extensive network of collaborators/tissue availability places our laboratory in a unique position to address fundamental mechanisms that will advance our understanding of both PBC and autoimmunity in general.
| Ma, Hong-Di; Zhao, Zhi-Bin; Ma, Wen-Tao et al. (2018) Gut microbiota translocation promotes autoimmune cholangitis. J Autoimmun 95:47-57 |
| Ma, Hong-Di; Ma, Wen-Tao; Liu, Qing-Zhi et al. (2017) Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation. J Autoimmun 78:19-28 |
| Tomiyama, Takashi; Yang, Guo-Xiang; Zhao, Ming et al. (2017) The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis. Cell Mol Immunol 14:276-284 |
| Shuai, Zongwen; Wang, Jinjun; Badamagunta, Madhu et al. (2017) The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis. Hepatology 65:1670-1682 |
| Tanakaa, Atsushi; Leung, Patrick Sc; Young, Howard A et al. (2017) Toward solving the etiological mystery of primary biliary cholangitis. Hepatol Commun 1:275-287 |
| Shuai, Zongwen; Leung, Miranda Wy; He, Xiaosong et al. (2016) Adaptive immunity in the liver. Cell Mol Immunol 13:354-68 |
| Wang, Lifeng; Gershwin, M Eric; Wang, Fu-Sheng (2016) Primary biliary cholangitis in China. Curr Opin Gastroenterol 32:195-203 |
| Floreani, Annarosa; Sun, Ying; Zou, Zheng Sheng et al. (2016) Proposed therapies in primary biliary cholangitis. Expert Rev Gastroenterol Hepatol 10:371-382 |
| Wang, Jinjun; Yang, Guoxiang; Dubrovsky, Alana Mari et al. (2016) Xenobiotics and loss of tolerance in primary biliary cholangitis. World J Gastroenterol 22:338-48 |
| Choi, Jinjung; Selmi, Carlo; Leung, Patrick S C et al. (2016) Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis. Expert Rev Clin Immunol 12:661-72 |
Showing the most recent 10 out of 226 publications
